Probiotics, prebiotics, and postbiotics in health and disease

被引:142
作者
Ji, Jing [1 ]
Jin, Weilin [2 ]
Liu, Shuang-Jiang [3 ]
Jiao, Zuoyi [4 ]
Li, Xiangkai [1 ]
机构
[1] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou, Gansu, Peoples R China
[2] Lanzhou Univ, Clin Med Coll 1, Med Frontier Innovat Res Ctr, Inst Canc Neurosci,Hosp 1, Lanzhou, Gansu, Peoples R China
[3] Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing, Peoples R China
[4] Lanzhou Univ, Cuiying Biomed Res Ctr, Hosp 2, Lanzhou, Gansu, Peoples R China
来源
MEDCOMM | 2023年 / 4卷 / 06期
基金
中国国家自然科学基金;
关键词
clinical trials; gut microbiota; postbiotics; prebiotics; probiotics; INTERNATIONAL SCIENTIFIC ASSOCIATION; GUT MICROBIOTA; CONSENSUS STATEMENT; FECAL MICROBIOTA; DIETARY FIBER; BIFIDOBACTERIA; ANTIBIOTICS; MODULATION; MECHANISMS; DYSBIOSIS;
D O I
10.1002/mco2.420
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The gut microbiota and its homeostasis play a crucial role in human health. However, for some diseases related to the gut microbiota, current traditional medicines can only relieve symptoms, and it is difficult to solve the root causes or even cause side effects like disturbances in the gut microbiota. Increasing clinical studies and evidences have demonstrated that probiotics, prebiotics, and postbiotics can prevent and treat various diseases, but currently they can only be used as dietary supplements rather than medicines, which restricts the application of probiotics in the field of medicine. Here, this review analyzes the importance of gut microbiota in human health and the current problems of traditional medicines, and systematically summarizes the effectiveness and mechanisms of probiotics, prebiotics, and postbiotics in maintaining health and treating diseases based on animal models and clinical trials. And based on current research outcomes and development trends in this field, the challenges and prospects of their clinical application in maintaining health, alleviating and treating diseases are analyzed. It is hoped to promote the application of probiotics, prebiotics, and postbiotics in disease treatment and open up new frontiers in probiotic research. Extensive research and clinical evidence have demonstrated the mechanisms and effectiveness of probiotics, prebiotics, and postbiotics in restoring gut microbiota homeostasis and treating a variety of diseases. Prebiotics can promote the growth of beneficial intestinal bacteria, while probiotics produce postbiotics through "addition" to regulate the gut microbiota, and "subtraction" to remove harmful metabolites and exogenous substances to reduce their impact on the body, thereby alleviating or treating diseases. Probiotics, prebiotics, and postbiotics may represent the next generation of medicines, with the potential to revolutionize the way we treat and manage disease.#image
引用
收藏
页数:23
相关论文
共 215 条
[1]   Aflatoxins biodetoxification strategies based on probiotic bacteria [J].
Afshar, Parvaneh ;
Shokrzadeh, Mohammad ;
Raeisi, Shahram Naghizadeh ;
Ghorbani-HasanSaraei, Azade ;
Nasiraii, Leila Roozbeh .
TOXICON, 2020, 178 :50-58
[2]   Plasma lipids and fatty acid synthase activity are regulated by short-chain fructo-oligosaccharides in sucrose-fed insulin-resistant rats [J].
Agheli, N ;
Kabir, M ;
Berni-Canani, S ;
Petitjean, E ;
Boussairi, A ;
Luo, J ;
Bornet, F ;
Slama, G ;
Rizkalla, SW .
JOURNAL OF NUTRITION, 1998, 128 (08) :1283-1288
[3]   Postbiotics: An evolving term within the functional foods field [J].
Aguilar-Toala, J. E. ;
Garcia-Varela, R. ;
Garcia, H. S. ;
Mata-Haro, V. ;
Gonzalez-Cordova, A. F. ;
Vallejo-Cordoba, B. ;
Hernandez-Mendoza, A. .
TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2018, 75 :105-114
[4]  
Akram M., 2023, Phytochemistry, Computational Tools and Databases in Drug Discovery, P27, DOI [10.1016/B978-0-323-90593-0.00008--3, DOI 10.1016/B978-0-323-90593-0.00008--3, 10.1016/B978-0-323-90593-0.00008-3, DOI 10.1016/B978-0-323-90593-0.00008-3]
[5]  
Aljuraiban GS., 2023, Saudi J Biol Sci, V30
[6]   OXALOBACTER-FORMIGENES GEN-NOV, SP-NOV - OXALATE-DEGRADING ANAEROBES THAT INHABIT THE GASTROINTESTINAL-TRACT [J].
ALLISON, MJ ;
DAWSON, KA ;
MAYBERRY, WR ;
FOSS, JG .
ARCHIVES OF MICROBIOLOGY, 1985, 141 (01) :1-7
[7]   In vitro assessment of prebiotic properties of xylooligosaccharides produced by Bacillus subtilis 3610 [J].
Amorim, Claudia ;
Silverio, Sara C. ;
Cardoso, Beatriz B. ;
Alves, Joana I. ;
Pereira, Maria Alcina ;
Rodrigues, Ligia R. .
CARBOHYDRATE POLYMERS, 2020, 229
[8]  
Aron-Wisnewsky J, 2020, GASTROENTEROLOGY, V158, P1881, DOI 10.1053/j.gastro.2020.01.049
[9]  
Bäckhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]
[10]   Advancements in the Pharmaceutical Applications of Probiotics: Dosage Forms and Formulation Technology [J].
Baral, Kshitis Chandra ;
Bajracharya, Rajiv ;
Lee, Sang Hoon ;
Han, Hyo-Kyung .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 :7535-7556